Logo image of AB9.DE

ABO ENERGY GMBH & CO. KGAA (AB9.DE) Stock Fundamental Analysis

FRA:AB9 - Deutsche Boerse Ag - DE0005760029 - Common Stock - Currency: EUR

37.7  0 (0%)

Fundamental Rating

5

AB9 gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 20 industry peers in the Independent Power and Renewable Electricity Producers industry. Both the profitability and the financial health of AB9 get a neutral evaluation. Nothing too spectacular is happening here. AB9 is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year AB9 was profitable.
AB9 had a negative operating cash flow in the past year.
In the past 5 years AB9 has always been profitable.
In the past 5 years AB9 reported 4 times negative operating cash flow.
AB9.DE Yearly Net Income VS EBIT VS OCF VS FCFAB9.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M -60M

1.2 Ratios

AB9 has a better Return On Assets (3.81%) than 75.00% of its industry peers.
AB9 has a Return On Equity of 11.06%. This is in the better half of the industry: AB9 outperforms 75.00% of its industry peers.
AB9's Return On Invested Capital of 6.81% is amongst the best of the industry. AB9 outperforms 95.00% of its industry peers.
AB9 had an Average Return On Invested Capital over the past 3 years of 8.25%. This is above the industry average of 3.98%.
Industry RankSector Rank
ROA 3.81%
ROE 11.06%
ROIC 6.81%
ROA(3y)4.96%
ROA(5y)4.96%
ROE(3y)12.67%
ROE(5y)11.01%
ROIC(3y)8.25%
ROIC(5y)8.39%
AB9.DE Yearly ROA, ROE, ROICAB9.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

AB9's Profit Margin of 5.59% is in line compared to the rest of the industry. AB9 outperforms 60.00% of its industry peers.
In the last couple of years the Profit Margin of AB9 has declined.
The Operating Margin of AB9 (13.60%) is comparable to the rest of the industry.
AB9's Operating Margin has declined in the last couple of years.
AB9's Gross Margin of 47.87% is in line compared to the rest of the industry. AB9 outperforms 60.00% of its industry peers.
AB9's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 13.6%
PM (TTM) 5.59%
GM 47.87%
OM growth 3Y-15.24%
OM growth 5Y-7.91%
PM growth 3Y-18.73%
PM growth 5Y-8.38%
GM growth 3Y-17.77%
GM growth 5Y-6.12%
AB9.DE Yearly Profit, Operating, Gross MarginsAB9.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AB9 is still creating some value.
AB9 has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for AB9 has been increased compared to 5 years ago.
Compared to 1 year ago, AB9 has a worse debt to assets ratio.
AB9.DE Yearly Shares OutstandingAB9.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
AB9.DE Yearly Total Debt VS Total AssetsAB9.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 2.94 indicates that AB9 is not a great score, but indicates only limited risk for bankruptcy at the moment.
AB9 has a better Altman-Z score (2.94) than 90.00% of its industry peers.
AB9 has a Debt/Equity ratio of 1.39. This is a high value indicating a heavy dependency on external financing.
AB9 has a Debt to Equity ratio of 1.39. This is in the lower half of the industry: AB9 underperforms 65.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.39
Debt/FCF N/A
Altman-Z 2.94
ROIC/WACC1.28
WACC5.33%
AB9.DE Yearly LT Debt VS Equity VS FCFAB9.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

AB9 has a Current Ratio of 10.63. This indicates that AB9 is financially healthy and has no problem in meeting its short term obligations.
AB9's Current ratio of 10.63 is amongst the best of the industry. AB9 outperforms 100.00% of its industry peers.
A Quick Ratio of 6.75 indicates that AB9 has no problem at all paying its short term obligations.
AB9 has a Quick ratio of 6.75. This is amongst the best in the industry. AB9 outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 10.63
Quick Ratio 6.75
AB9.DE Yearly Current Assets VS Current LiabilitesAB9.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

7

3. Growth

3.1 Past

AB9 shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.22%.
AB9 shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.74% yearly.
AB9 shows a strong growth in Revenue. In the last year, the Revenue has grown by 49.00%.
The Revenue has been growing by 28.71% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-7.22%
EPS 3Y23.36%
EPS 5Y14.74%
EPS Q2Q%-22.56%
Revenue 1Y (TTM)49%
Revenue growth 3Y51.96%
Revenue growth 5Y28.71%
Sales Q2Q%91.72%

3.2 Future

Based on estimates for the next years, AB9 will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.09% on average per year.
AB9 is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.60% yearly.
EPS Next Y27.76%
EPS Next 2Y26.49%
EPS Next 3Y23.28%
EPS Next 5Y17.09%
Revenue Next Year5.29%
Revenue Next 2Y10.37%
Revenue Next 3Y11.05%
Revenue Next 5Y10.6%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
AB9.DE Yearly Revenue VS EstimatesAB9.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M
AB9.DE Yearly EPS VS EstimatesAB9.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 13.96, AB9 is valued correctly.
Based on the Price/Earnings ratio, AB9 is valued a bit cheaper than 65.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of AB9 to the average of the S&P500 Index (26.25), we can say AB9 is valued slightly cheaper.
The Price/Forward Earnings ratio is 10.53, which indicates a very decent valuation of AB9.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AB9 indicates a rather cheap valuation: AB9 is cheaper than 85.00% of the companies listed in the same industry.
AB9 is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.15, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.96
Fwd PE 10.53
AB9.DE Price Earnings VS Forward Price EarningsAB9.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

65.00% of the companies in the same industry are more expensive than AB9, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.11
AB9.DE Per share dataAB9.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

AB9's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AB9's earnings are expected to grow with 23.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.5
PEG (5Y)0.95
EPS Next 2Y26.49%
EPS Next 3Y23.28%

More info and screens

5

5. Dividend

5.1 Amount

AB9 has a Yearly Dividend Yield of 1.68%.
Compared to an average industry Dividend Yield of 3.80, AB9 has a dividend in line with its industry peers.
AB9's Dividend Yield is slightly below the S&P500 average, which is at 2.40.
Industry RankSector Rank
Dividend Yield 1.68%

5.2 History

On average, the dividend of AB9 grows each year by 7.98%, which is quite nice.
Dividend Growth(5Y)7.98%
Div Incr Years2
Div Non Decr Years2
AB9.DE Yearly Dividends per shareAB9.DE Yearly Dividends per shareYearly Dividends per share 2020 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

AB9 pays out 22.12% of its income as dividend. This is a sustainable payout ratio.
AB9's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP22.12%
EPS Next 2Y26.49%
EPS Next 3Y23.28%
AB9.DE Yearly Income VS Free CF VS DividendAB9.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M
AB9.DE Dividend Payout.AB9.DE Dividend Payout, showing the Payout Ratio.AB9.DE Dividend Payout.PayoutRetained Earnings

More info and screens

ABO ENERGY GMBH & CO. KGAA

FRA:AB9 (5/30/2025, 7:00:00 PM)

37.7

0 (0%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)03-24 2025-03-24/amc
Earnings (Next)N/A N/A
Inst Owners2.91%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap347.59M
Analysts85.71
Price Target103.7 (175.07%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.68%
Yearly Dividend0.6
Dividend Growth(5Y)7.98%
DP22.12%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.67%
PT rev (3m)-0.97%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)12.47%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.3%
Valuation
Industry RankSector Rank
PE 13.96
Fwd PE 10.53
P/S 0.78
P/FCF N/A
P/OCF N/A
P/B 1.54
P/tB 1.54
EV/EBITDA 10.11
EPS(TTM)2.7
EY7.16%
EPS(NY)3.58
Fwd EY9.5%
FCF(TTM)-0.79
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS48.48
BVpS24.51
TBVpS24.41
PEG (NY)0.5
PEG (5Y)0.95
Profitability
Industry RankSector Rank
ROA 3.81%
ROE 11.06%
ROCE 10.19%
ROIC 6.81%
ROICexc 6.81%
ROICexgc 6.82%
OM 13.6%
PM (TTM) 5.59%
GM 47.87%
FCFM N/A
ROA(3y)4.96%
ROA(5y)4.96%
ROE(3y)12.67%
ROE(5y)11.01%
ROIC(3y)8.25%
ROIC(5y)8.39%
ROICexc(3y)9.19%
ROICexc(5y)9.67%
ROICexgc(3y)9.23%
ROICexgc(5y)9.92%
ROCE(3y)12.35%
ROCE(5y)12.54%
ROICexcg growth 3Y-2.24%
ROICexcg growth 5Y-5.63%
ROICexc growth 3Y-2.09%
ROICexc growth 5Y-3.97%
OM growth 3Y-15.24%
OM growth 5Y-7.91%
PM growth 3Y-18.73%
PM growth 5Y-8.38%
GM growth 3Y-17.77%
GM growth 5Y-6.12%
F-Score3
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 1.39
Debt/FCF N/A
Debt/EBITDA 4.84
Cap/Depr 92.99%
Cap/Sales 0.89%
Interest Coverage 5.53
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.63
Quick Ratio 6.75
Altman-Z 2.94
F-Score3
WACC5.33%
ROIC/WACC1.28
Cap/Depr(3y)101.36%
Cap/Depr(5y)118.81%
Cap/Sales(3y)1.65%
Cap/Sales(5y)1.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.22%
EPS 3Y23.36%
EPS 5Y14.74%
EPS Q2Q%-22.56%
EPS Next Y27.76%
EPS Next 2Y26.49%
EPS Next 3Y23.28%
EPS Next 5Y17.09%
Revenue 1Y (TTM)49%
Revenue growth 3Y51.96%
Revenue growth 5Y28.71%
Sales Q2Q%91.72%
Revenue Next Year5.29%
Revenue Next 2Y10.37%
Revenue Next 3Y11.05%
Revenue Next 5Y10.6%
EBIT growth 1Y11.48%
EBIT growth 3Y28.8%
EBIT growth 5Y18.52%
EBIT Next Year65.62%
EBIT Next 3Y30.59%
EBIT Next 5YN/A
FCF growth 1Y89.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y94.73%
OCF growth 3YN/A
OCF growth 5YN/A